Related Experiment Video
Updated: Feb 14, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
A pilot study of a novel therapeutic approach to obesity: CNS modification by N.I.R. H.E.G. neurofeedback
Ruth Percik1, Jenny Cina2, Batel Even3
1The Institute of Endocrinology, Sheba Medical Center, Tel-Hashomer, 52621, Israel; The Cancer Center, Sheba Medical Center, Israel.
Background & Aims:
Despite the thorough mapping of brain pathways involved in eating behavior, no treatment aimed at modulating eating dysregulation from its neurocognitive root has been established yet. We aimed to evaluate the effect of N.I.R. H.E.G. (Near Infra-Red Hemoencephalography) neurofeedback training on appetite control, weight and food-related brain activity.
Methods:
Six healthy male participants with overweight or mild obesity went through 10 N.I.R. H.E.G. neurofeedback sessions designed to practice voluntary activation of the prefrontal cortex. Weight, eating behavior, appetite control and brain activity related to food and self-inhibition based on fMRI were evaluated before and after neurofeedback training.
Results:
Our study group demonstrated a positive trend of increased self-control and inhibition related to food behavior, reduced weight and increased activation during an fMRI response-inhibition task (Go-No-Go - GNG) in the predefined region of interest (ROI): superior orbitofrontal cortex (sOFC).
Conclusions:
N.I.R. H.E.G. holds a promising potential as a feasible neurofeedback platform for modulation of cortical brain circuits involved in self-control and eating behavior and should be further evaluated and developed as a brain modifying device for the treatment and prevention of obesity.
Related Concept Videos
Obesity
Pilot and Numeric Relaying
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Spreading of Chromatin Modifications
Writers
The writer...
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines

